D. E. Shaw & Co., Inc. Uni Qure N.V. Transaction History

D. E. Shaw & Co., Inc.

$125 Billion
Q2 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Uni Qure N.V. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 27,531 shares of QURE stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,531

Previous 16,700 64.86%

Holding current value

$1.76 Million

Previous $177,000 116.38%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.34 - $17.27 $229,608 - $475,460	27,531 New	27,531 $383,000
Q4 2024 Feb 14, 2025	SELL	$4.54 - $17.73 $2.01 Million - $7.87 Million	-443,727 Reduced 59.68%	299,771 $5.29 Million
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $633,112 - $1.69 Million	167,490 Added 29.08%	743,498 $3.67 Million
Q2 2024 Aug 14, 2024	SELL	$4.39 - $5.43 $1.2 Million - $1.49 Million	-274,092 Reduced 32.24%	576,008 $2.58 Million
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $1.4 Million - $2.01 Million	289,769 Added 51.71%	850,100 $4.42 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $836,589 - $1.23 Million	148,595 Added 36.09%	560,331 $3.79 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $2.63 Million - $4.63 Million	391,621 Added 1946.91%	411,736 $2.76 Million
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $223,678 - $446,553	20,115 New	20,115 $230,000
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $148,595 - $231,085	11,300 New	11,300 $211,000
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $693,046 - $996,195	-23,702 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $178,164 - $255,376	5,040 Added 27.01%	23,702 $856,000
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $52,044 - $78,239	1,155 Added 6.6%	18,662 $841,000
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $455,633 - $842,370	11,388 Added 186.11%	17,507 $831,000
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $754,555 - $1.52 Million	-20,322 Reduced 76.86%	6,119 $438,000
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $3.79 Million - $7.39 Million	-96,219 Reduced 78.44%	26,441 $1.04 Million
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $2.55 Million - $6.36 Million	93,003 Added 313.6%	122,660 $7.32 Million
Q4 2018 Feb 14, 2019	SELL	$22.8 - $33.93 $877,708 - $1.31 Million	-38,496 Reduced 56.48%	29,657 $855,000
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $859,596 - $1.24 Million	-28,894 Reduced 29.77%	68,153 $2.48 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $65 - $119	3 Added 0.0%	97,047 $3.67 Million
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $160,705 - $250,080	-9,398 Reduced 8.83%	97,044 $2.28 Million
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $1.01 Million - $2.09 Million	106,442	106,442 $2.09 Million

Others Institutions Holding QURE

# of Institutions

190

Shares Held

51.8M

Call Options Held

4.43M

Put Options Held

1.27M

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $2.99B
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account